Literature DB >> 8635747

Escherichia coli beta-galactosidase as an in vitro and in vivo reporter enzyme and stable transfection marker in the intracellular protozoan parasite Toxoplasma gondii.

F Seeber1, J C Boothroyd.   

Abstract

We have developed several protocols for the use of beta-galactosidase (betaGal) from Escherichia coli as a reporter enzyme in transfection studies of Toxoplasma gondii (Tg) and as a readily screenable marker for stable transformation. Three Tg expression vectors with different promoters driving lacZ were constructed and shown in transient transfections to differ in their relative expression levels. Using a fluorescent betaGal substrate, it was possible to detect enzymatic activity with as little as 50 ng of transfected lacZ-containing plasmid DNA. When stably transformed intracellular parasites were cultivated in microtiter plates in the presence of the color substrate, chorophenol red-beta-D-galactopyranoside (CPRG), the signal from as few as 400 Tg could be readily detected by eye. Using serial dilutions of transfected parasite cultures in the presence of CPRG, we were able to clone stably expressing betaGal-positive Tg without the need for another selectable marker. Such lacZ transgenics could also be visualized histochemically in the tissue of infected mice. Thus, the application of betaGal to studies on Tg provides not only a much needed second reporter for transient transfection, it also comprises a safe and sensitive marker for the generation and analysis of stably transfected parasites.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8635747     DOI: 10.1016/0378-1119(95)00786-5

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  34 in total

Review 1.  The development and biology of bradyzoites of Toxoplasma gondii.

Authors:  L M Weiss; K Kim
Journal:  Front Biosci       Date:  2000-04-01

2.  Ionophore-resistant mutants of Toxoplasma gondii reveal host cell permeabilization as an early event in egress.

Authors:  M W Black; G Arrizabalaga; J C Boothroyd
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

Review 3.  Lytic cycle of Toxoplasma gondii.

Authors:  M W Black; J C Boothroyd
Journal:  Microbiol Mol Biol Rev       Date:  2000-09       Impact factor: 11.056

4.  Serine protease inhibitors block invasion of host cells by Toxoplasma gondii.

Authors:  V Conseil; M Soête; J F Dubremetz
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

Review 5.  Toxoplasma gondii: the model apicomplexan.

Authors:  Kami Kim; Louis M Weiss
Journal:  Int J Parasitol       Date:  2004-03-09       Impact factor: 3.981

6.  Cyclic nucleotide kinases and tachyzoite-bradyzoite transition in Toxoplasma gondii.

Authors:  Michael S Eaton; Louis M Weiss; Kami Kim
Journal:  Int J Parasitol       Date:  2005-09-22       Impact factor: 3.981

7.  Transgenic Plasmodium berghei sporozoites expressing beta-galactosidase for quantification of sporozoite transmission.

Authors:  Sabine Engelmann; Photini Sinnis; Kai Matuschewski
Journal:  Mol Biochem Parasitol       Date:  2005-11-15       Impact factor: 1.759

8.  A cluster of four surface antigen genes specifically expressed in bradyzoites, SAG2CDXY, plays an important role in Toxoplasma gondii persistence.

Authors:  Jeroen P J Saeij; Gustavo Arrizabalaga; John C Boothroyd
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

9.  Methodological advances in drug discovery for Chagas disease.

Authors:  Juan M Bustamante; Rick L Tarleton
Journal:  Expert Opin Drug Discov       Date:  2011-06       Impact factor: 6.098

10.  Discovery of compounds blocking the proliferation of Toxoplasma gondii and Plasmodium falciparum in a chemical space based on piperidinyl-benzimidazolone analogs.

Authors:  Nadia Saïdani; Cyrille Y Botté; Michael Deligny; Anne-Laure Bonneau; Janette Reader; Ronald Lasselin; Goulven Merer; Alisson Niepceron; Fabien Brossier; Jean-Christophe Cintrat; Bernard Rousseau; Lyn-Marie Birkholtz; Marie-France Cesbron-Delauw; Jean-François Dubremetz; Corinne Mercier; Henri Vial; Roman Lopez; Eric Maréchal
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.